Clinical Trial Unit / Clinical Trial Office

The Department of Internal Medicine III has a Clinical Trial Unit (CTU) with a team of highly trained medical doctors and oncology study nurses. Currently, more than 70 clinical trials of phase I-II (early development of novel and promising anti-cancer agents) and of phase III-IV (randomized treatment trials) are active. A large proportion of patients are treated within such controlled clinical trials, thereby ensuring innovation and highest quality in patient care.

All trial activities are coordinated by trained personnel in our Clinical Trials Office (CTO) which also harbors the Central Clinical Trial Office of the German-Austrian Acute Myeloid Leukemia Study Group (AMLSG).